Back

Lymphocyte-to–C-reactive-protein ratio is a strong predictor of mortality risk in cardiac transthyretin amyloidosis

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Diagnosis and risk stratification in cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Vladimir Cejka

Comprehensive Heart Failure Center (CHFC), Wurzburg (Germany)

6 More presentations in this session

Presentation thumbnail
Idiopathic carpal tunnel syndrome as an early clinical indicator of transthyretin cardiac amyloidosis: diagnostic insights
Doctor E. Martins (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Transthyretin gene variants in a population-based study of 9,957 Finnish men and in 366 Finnish patients with hypertrophic cardiomyopathy
Doctor T. Pennanen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Safety, diagnostic yield and clinical utility of endomyocardial biopsy in patients with suspected cardiac amyloidosis: a 10-year consecutive single-centre experience
Doctor J. Mansell (London, GB)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmias in ATTR-CM: frequency, disease severity and risk of sudden cardiac death
Doctor K. Knoll (Munich, DE)
Abstract Slides Video
Presentation thumbnail
AI-guided population screening for cardiac ATTR amyloidosis in heart failure patients within ambulatory health service's database
Doctor I. Davarashvili (Jerusalem, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and risk stratification in cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
The value of left atrio-ventricular coupling index (LACI) in transthyretin amyloidosis: insights from a cohort analysis
29 August 2025
thumbnail
Congress Presentation
Red blood cell distribution width and red blood cell distribution width/albumin ratio as predictors of mortality in light chain cardiac amyloidosis
29 August 2025
thumbnail
Congress Presentation
Assessment of individual and combined ACC scientific statement-recommended inflammatory markers for long-term prognostication in coronary heart disease: a two-cohort study
29 August 2026
thumbnail
Congress Presentation
Anemia and outcome in cardiac amyloidosis
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources